333 results on '"Gomes CC"'
Search Results
2. HIV-related non-Hodgkin lymphomas affecting the oral cavity: a clinicopathologic study of 11 cases
- Author
-
Uchôa, DC., primary, Pontes, FS., additional, Souza, LL., additional, Santos, GS., additional, Prado-Ribeiro, AC., additional, Brandão, TB., additional, Oliveira, LR., additional, Gomes, CC., additional, Santos-Silva, AR., additional, Fonseca, FP., additional, Almeida, FP., additional, and Pontes, HA., additional
- Published
- 2020
- Full Text
- View/download PDF
3. Intra-abdominal gossypiboma: Still a severe postoperative complication
- Author
-
Gomes Cc, Junior Cs, Ramos Add, de Assis Lopes Ct, de Oliveira Nascimento R, Nogueira Jm, de Souza Ek, de Souza Kvt, Gomes Fc, and Gomes Ca
- Subjects
medicine.medical_specialty ,business.industry ,medicine ,Gossypiboma ,Postoperative complication ,medicine.disease ,business ,Surgery - Published
- 2017
4. Familial STAG2 germline mutation defines a new human cohesinopathy
- Author
-
Soardi, FC, Machado-Silva, A, Linhares, ND, Zheng, G, Qu, Q, Pena, HB, Martins, TMM, Vieira, HGS, Pereira, NB, Melo-Minardi, RC, Gomes, CC, Gomez, RS, Gomes, DA, Pires, DEV, Ascher, DB, Yu, H, Pena, SDJ, Soardi, FC, Machado-Silva, A, Linhares, ND, Zheng, G, Qu, Q, Pena, HB, Martins, TMM, Vieira, HGS, Pereira, NB, Melo-Minardi, RC, Gomes, CC, Gomez, RS, Gomes, DA, Pires, DEV, Ascher, DB, Yu, H, and Pena, SDJ
- Abstract
We characterize a novel human cohesinopathy originated from a familial germline mutation of the gene encoding the cohesin subunit STAG2, which we propose to call STAG2-related X-linked Intellectual Deficiency. Five individuals carry a STAG2 p.Ser327Asn (c.980 G > A) variant that perfectly cosegregates with a phenotype of syndromic mental retardation in a characteristic X-linked recessive pattern. Although patient-derived cells did not show overt sister-chromatid cohesion defects, they exhibited altered cell cycle profiles and gene expression patterns that were consistent with cohesin deficiency. The protein level of STAG2 in patient cells was normal. Interestingly, STAG2 S327 is located at a conserved site crucial for binding to SCC1 and cohesin regulators. When expressed in human cells, the STAG2 p.Ser327Asn mutant is defective in binding to SCC1 and other cohesin subunits and regulators. Thus, decreased amount of intact cohesin likely underlies the phenotypes of STAG2-SXLID. Intriguingly, recombinant STAG2 p.Ser327Asn binds normally to SCC1, WAPL, and SGO1 in vitro, suggesting the existence of unknown in vivo mechanisms that regulate the interaction between STAG2 and SCC1.
- Published
- 2017
5. Allelic loss in amalgam-associated oral lichenoid lesions compared to oral lichen planus and mucosa
- Author
-
Rodrigues, LN, primary, Sousa, SF, additional, Silva, RCC, additional, Abreu, MHG, additional, Pires, FR, additional, Mesquita, RA, additional, Bastos-Rodrigues, L, additional, De Marco, L, additional, Gomes, CC, additional, Gomez, RS, additional, and Bernardes, VF, additional
- Published
- 2017
- Full Text
- View/download PDF
6. Local biological drivers, not remote forcing, predict settlement rate to a subtropical barnacle population
- Author
-
Barbosa, ACC, primary, Gomes, CC, additional, Pereira, GC, additional, Bueno, M, additional, and Flores, AAV, additional
- Published
- 2016
- Full Text
- View/download PDF
7. Recurrent aphthous stomatitis and Helicobacter pylori
- Author
-
Gomes, CC, primary, Gomez, RS, additional, Zina, LG, additional, and Amaral, FR, additional
- Published
- 2016
- Full Text
- View/download PDF
8. Oral leukoplakia: What is achieved by surgical treatment?
- Author
-
Gomes, CC, primary and Gomez, RS, primary
- Published
- 2013
- Full Text
- View/download PDF
9. AMBN (ameloblastin (enamel matrix protein))
- Author
-
Diniz, MG, primary, Gomez, RS, additional, Gomes, CC, additional, and Guimarães, ALS, additional
- Published
- 2012
- Full Text
- View/download PDF
10. Impact of WWOX alterations on p73, ΔNp73, p53, cell proliferation and DNA ploidy in salivary gland neoplasms
- Author
-
Gomes, CC, primary, Diniz, MG, additional, Oliveira, CS, additional, Tavassoli, M, additional, Odell, EW, additional, Gomez, RS, additional, and De Marco, L, additional
- Published
- 2011
- Full Text
- View/download PDF
11. Microchimerism in labial salivary glands of hematopoietic stem cell transplanted patients
- Author
-
Souza, LN, primary, Faria, DR, additional, Dutra, WO, additional, Gomes, CC, additional, and Gomez, RS, additional
- Published
- 2010
- Full Text
- View/download PDF
12. Source populations in coastal crabs: population parameters affecting egg production
- Author
-
Flores, AAV, primary, Gomes, CC, additional, and Villano, WF, additional
- Published
- 2009
- Full Text
- View/download PDF
13. Herpes simplex virus type 1 shedding in the oral cavity of seropositive patients
- Author
-
da Silva, LM, primary, Guimaraes, ALS, additional, Victoria, JMN, additional, Gomes, CC, additional, and Gomez, RS, additional
- Published
- 2005
- Full Text
- View/download PDF
14. Microchimerism in labial salivary glands of hematopoietic stem cell transplanted patients.
- Author
-
Souza, LN, Faria, DR, Dutra, WO, Gomes, CC, and Gomez, RS
- Subjects
STEM cell transplantation ,ANALYSIS of variance ,BIOPSY ,CHROMOSOME abnormalities ,LIPS ,RESEARCH ,SALIVARY glands ,SEX distribution - Abstract
Oral Diseases (2011) , 484-488 Microchimerism has been extensively investigated in autoimmune diseases, which display similarities with graft- vs-host disease. This study was conducted to investigate the presence of microchimerism in minor salivary glands of hematopoietic stem cell transplanted patients, one of the targets of graft- vs-host disease. Labial salivary glands biopsy specimens from 11 stem cell transplanted patients were analysed. The samples were grouped in control (five specimens from a female-to-female transplantation) and study group (five glands from male-to-female transplantation). One male transplanted patient was used as a positive control. Fluorescence in situ hybridization with Y-chromosome probe and immunofluorescence with anticytokeratin AE1/AE3 and CD45 were used to identify Y-chromosome positive glandular epithelial cells from allogeneic hematopoietic stem cell transplanted patients. In the study group, all samples were positive to Y-chromosome and cytokeratin AE1/AE3, in agreement with the pattern exhibited by male labial salivary gland. None of the samples from control group were positive to Y-chromosome despite being positive to cytokeratin AE1/AE3. Positivity to CD45 was not relevant. Microchimerism in the labial salivary glands of sex-mismatched stem cell transplanted patients is a real phenomenon. Further studies are necessary to elucidate the impact of this phenomenon on the clinical status of stem cell transplanted patients. [ABSTRACT FROM AUTHOR]
- Published
- 2011
- Full Text
- View/download PDF
15. P21/ WAF1 and cyclin D1 variants and oral squamous cell carcinoma.
- Author
-
Gomes CC, Drummond SN, Guimaraes AL, Andrade CI, Mesquita RA, and Gomez RS
- Abstract
BACKGROUND: Genetic factors are known to be involved in oral squamous cell carcinoma (OSCC) development. METHOD: We evaluated a possible association between CCND1 A870G and P21/WAF1 C98A polymorphisms and OSCC, as well as the impact of the genotypes on protein immunoexpression. The study group consisted of 80 individuals with histopathological diagnosis of OSCC and the control group consisted of 80 healthy individuals without oral lesions and matched by age, sex and tobacco usage. The genotypes were studied by the polymerase chain reaction and restriction fragment length polymorphic analysis. Paraffin-embedded sections were used for immunohistochemical analysis. RESULTS: No statistical association between CCND1 and/or P21/WAF1 genotypes and OSCC was demonstrated, although we found that people harbouring the combined presence of at least one variant allele of both genes showed a 1.8 times more chance of developing OSCC compared to the referent genotype. OSCC tumours from individuals with P21 heterozygous genotype showed a significantly higher immunopositivity than tumours from wild-type individuals. CONCLUSION: The present study did not demonstrate a significant association between CCND1 and / or P21 / WAF1 genotypes and OSCC. However, P21 protein expression in OSCC tumours is affected by P21 / WAF1 genotype. [ABSTRACT FROM AUTHOR]
- Published
- 2008
- Full Text
- View/download PDF
16. Giant Cell Granuloma of the Jaws and Keratin-Positive Giant Cell-Rich Tumor of Bone and Soft Tissue.
- Author
-
Coura BP, Sant'Ana MSP, Fonseca FP, de Sousa SF, Gomes CC, and Gomez RS
- Subjects
- Humans, Female, Male, Adult, Middle Aged, Young Adult, Immunohistochemistry, Aged, Jaw Neoplasms pathology, Jaw Neoplasms metabolism, Soft Tissue Neoplasms pathology, Soft Tissue Neoplasms metabolism, Adolescent, Giant Cell Tumors pathology, Giant Cell Tumors metabolism, Granuloma, Giant Cell pathology, Granuloma, Giant Cell metabolism, Keratins, Jaw Diseases pathology, Jaw Diseases metabolism
- Abstract
Background: Different giant cell-rich tumors may occur in the jaws. Recently, a new condition known as keratin-positive giant-cell rich tumor harboring recurrent HMGA2::NCOR2 fusions has been described. Interestingly, the mononuclear cells of this tumor are immunoreactive with the AE1/AE3 keratin. Considering the similarities of central and peripheral giant cell granuloma of the jaws with the keratin-positive giant cell-rich tumor of the soft tissue and bone, we hypothesized whether the keratin-positive tumors could also occur in the maxillary bones., Methods and Results: An immunohistochemical investigation of AE1/AE3 in a cohort of 16 cases of peripheral and central giant cell granuloma of the jaws was carried out. None of the cases was keratin-positive., Conclusions: Although no immunopositivity for keratin was observed in the present giant cell granulomas cohort, we cannot completely exclude the possibility of keratin-positive giant cell-rich tumors occurring in the jaws. Therefore, oral pathologists should be aware about this condition and further studies using cohorts from different laboratories are necessary., (© 2024 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.)
- Published
- 2024
- Full Text
- View/download PDF
17. MMP13 Expression and Activity Suggest Its Role in Bone Resorption in Ameloblastomas.
- Author
-
Valeriano AT, Camara LS, Bernardes VF, Pais FS, Araújo FMG, Salim ACM, Fernandes GDR, Stussi F, Gomes CC, de Andrade Santos PP, de Souza LB, Gomez RS, and Diniz MG
- Subjects
- Humans, Jaw Neoplasms pathology, Jaw Neoplasms metabolism, Male, Female, Adult, Middle Aged, RNA, Messenger, Ameloblastoma pathology, Matrix Metalloproteinase 13 metabolism, Bone Resorption pathology
- Abstract
Background: Ameloblastoma is a locally destructive benign odontogenic tumor. While the neoplastic cells of conventional ameloblastoma can infiltrate the connective tissue and bone, in unicystic ameloblastoma the epithelium is encapsulated. The mechanisms driving ameloblastoma's bone resorption remains unclear., Methods: RNA sequencing (RNA-seq) was performed in a discovery cohort of conventional ameloblastoma, and pathway enrichment analysis was carried out. mRNA levels of MMP13, a gene associated with bone resorption, were assessed using RT-qPCR in a larger cohort of conventional ameloblastoma and in unicystic ameloblastoma. Zymogram gels and the immunoexpression profile of collagenase 3 (encoded by MMP13 gene) were evaluated as well., Results: Enriched pathways related to bone mineralization and upregulation of MMP13 were observed in ameloblastomas. Collagenolytic activity of collagenase 3 was detected in the tumor lysates. Collagenase 3 immunopositivity was observed in ameloblastomatous epithelium infiltrating the fibrous capsule of unicystic ameloblastoma. At the tumor-bone interface, collagenase 3 expression was detected in stromal cells, osteoblasts, and osteocytes., Conclusion: The results indicate a potential involvement of MMP13 in ameloblastoma-related bone resorption and progression., (© 2024 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.)
- Published
- 2024
- Full Text
- View/download PDF
18. The evolving molecular characterisation, histological criteria and nomenclature of adenoid ameloblastoma as a World Health Organisation tumour type.
- Author
-
Odell EW, Gomes CC, and Thavaraj S
- Subjects
- Humans, Jaw Neoplasms pathology, Jaw Neoplasms classification, Jaw Neoplasms genetics, Ameloblastoma pathology, Ameloblastoma classification, Ameloblastoma genetics, World Health Organization, Terminology as Topic
- Abstract
Adenoid ameloblastoma (AA) was recently recognised as a separate tumour type in the most recent World Health Organisation (WHO) classification of head and neck tumours. This decision has been considered controversial by several groups, who have described AA as a subtype of ameloblastoma, a hybrid odontogenic tumour or to fall within the spectrum of other recognised odontogenic tumours, including dentinogenic ghost cell tumour and adenomatoid odontogenic tumour. Here we review the reasons for the WHO decision to classify AA as a separate tumour type. We also critique molecular and histological findings from recent reports published since the WHO classification. While acknowledging that the classification of tumours is constantly evolving, the balance of current evidence suggests that AA should remain a distinct tumour type, and not a subtype of ameloblastoma, pending further molecular characterisation., (© 2024 The Author(s). Histopathology published by John Wiley & Sons Ltd.)
- Published
- 2024
- Full Text
- View/download PDF
19. Whole-exome sequencing and copy number alterations analysis in a case of expansive florid cemento-osseous dysplasia.
- Author
-
Gomes CC, Bastos VC, El Mouatani A, Duarte-Andrade FF, Jabado N, de Castro WH, and Gomez RS
- Abstract
Whole-exome sequencing (WES) analysis of an expansive case florid cemento-osseus dysplasia were reported for the first time. Also, the new potential candidate genes were reported to expand our knowledge about their molecular pathogenesis., Abstract: We report a case of expansive florid cemento-osseus dysplasia in a 32-year-old female patient who presented an expansive tumoral lesion in the anterior mandible. As florid cemento-osseus dysplasia have only been molecularly investigated using targeted-sequencing, fragments of the lesion were collected and subjected to molecular investigation using WES to assess somatic mutations as well as copy number alterations. No gains and losses of chromosomal arms or segments longer than 1 Mb were detected. Our findings revealed a pathogenic stopgain variant at the KIF5C gene, a stoploss variant at MAPK10, and missense SNV at COL6A2 at DCDC1, suggesting potential candidate genes associated with florid cemento-osseus dysplasia., Competing Interests: The authors declare that they have no conflict of interest., (© 2024 The Author(s). Clinical Case Reports published by John Wiley & Sons Ltd.)
- Published
- 2024
- Full Text
- View/download PDF
20. Tenosynovial giant cell tumor: case report and molecular investigation.
- Author
-
Guimarães LM, Bastos VC, Souza MRF, de Castro WH, Gomes CC, and Gomez RS
- Subjects
- Humans, Female, Middle Aged, Diagnosis, Differential, Biopsy, Temporomandibular Joint Disorders pathology, Temporomandibular Joint Disorders surgery, Temporomandibular Joint Disorders genetics, Receptor, Fibroblast Growth Factor, Type 1 genetics, DNA Mutational Analysis, Proto-Oncogene Proteins p21(ras), Giant Cell Tumor of Tendon Sheath pathology, Giant Cell Tumor of Tendon Sheath genetics, Giant Cell Tumor of Tendon Sheath surgery
- Abstract
Tenosynovial giant cell tumor is a benign neoplasm arising from the synovium of joints, including the temporomandibular joint (TMJ). Despite its benign nature, these tumors may exhibit aggressive behavior. A 57-year-old woman with a swollen, hardened area in the left TMJ was referred to the university´s clinic. The diagnosis of tenosynovial giant cell tumor was made based on the presence of hyperplastic synovial lining containing mononuclear and giant cells, hemorrhagic areas, hemosiderin deposits, and calcification foci in the biopsy. A low condylectomy was performed, and histopathologic analysis of the surgical piece upheld the diagnosis. Due to histopathologic resemblance with other giant cell-rich lesions (giant cell granuloma of the jaws, brown tumor of hyperparathyroidism, and non-ossifying fibroma) for which signature mutations are known, mutational analysis of KRAS, FGFR1, and TRPV4 genes was conducted. The results revealed wild-type sequences for all the mutations tested, thereby supporting the diagnosis of tenosynovial giant cell tumor., (Copyright © 2024 Elsevier Inc. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
21. Shaping Ability of TRUShape and XP-endo Shaper in C-Shaped Canals Using 3D-Printed Replicas: A Micro-CT Study.
- Author
-
Falcão NPDS, Marceliano-Alves MF, Tavares SJO, Amoroso-Silva P, Neves AA, Bastos LF, Lopes RT, Dantas WCF, Galhardi MPW, Marceliano EFV, and Gomes CC
- Abstract
Objective: This study compared the shaping ability of TRUShape and XP-endo Shaper systems on C-shaped root canals replicas using microcomputed tomography (micro-CT)., Material and Methods: Thirty three-dimensional replicas based on a mandibular second molar classified as C1 type I C-shaped canal were randomly divided into two groups ( n = 15): TRUShape (G.TRU) and XP-endo Shaper (G.XP) and instrumented with each system according to the manufacturer's instructions. Changes in volume and surface and the unprepared area of the root canal were measured by scanning on micro-CT before and after instrumentation., Results: The unprepared areas were 39% in the G.TRU and 43% in the G.XP group with no significant difference between them ( p > 0.05), but both the tested systems left a high percentage of unprepared root canal walls of C-shaped root canals., Conclusion: TRUShape and XP-endo Shaper showed a high rate of unprepared areas with similar results after C-shaped root canals replicas for root canal preparation., Competing Interests: None declared., (The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/).)
- Published
- 2024
- Full Text
- View/download PDF
22. High glucose impairs human periodontal ligament cells migration through lowered microRNAs 221 and 222.
- Author
-
Monteiro MM, Gomes CC, Cruz MC, Horliana ACRT, Hamassaki DE, Lima CR, and Santos MF
- Subjects
- Humans, Fibronectins pharmacology, Periodontal Ligament metabolism, Cell Movement, Glucose pharmacology, Cells, Cultured, MicroRNAs metabolism
- Abstract
Objective: To investigate the effects of miR-221 and miR-222 and high glucose on human periodontal ligament (PL) cells morphology, cytoskeleton, adhesion, and migration., Background: Chronic hyperglycemia is common in uncontrolled diabetes mellitus (DM) and plays a central role in long-term DM complications, such as impaired periodontal healing. We have previously shown that high glucose increases apoptosis of human PL cells by inhibiting miR-221 and miR-222 and consequently augmenting their target caspase-3. However, other effects of miR-221/222 downregulation on PL cells are still unknown., Methods: Cells from young humans' premolar teeth were cultured for 7 days under 5 or 30 mM glucose. Directional and spontaneous migration on fibronectin were studied using transwell and time-lapse assays, respectively. F-actin staining was employed to study cell morphology and the actin cytoskeleton. MiR-221 and miR-222 were inhibited using antagomiRs, and their expressions were evaluated by real-time RT-PCR., Results: High glucose inhibited PL cells early adhesion, spreading, and migration on fibronectin. Cells exposed to high glucose showed reduced polarization, velocity, and directionality. They formed several simultaneous unstable and short-lived protrusions, suggesting impairment of adhesion maturation. MiR-221 and miR-222 inhibition also reduced migration, decreasing cell directionality but not significantly cell velocity. After miR-221 and miR-222 downregulation cells showed morphological resemblance with cells exposed to high glucose., Conclusion: High glucose impairs human PL cells migration potentially through a mechanism involving reduction of microRNA-221 and microRNA-222 expression. These effects may contribute to the impairment of periodontal healing, especially after surgery and during guided regeneration therapies., (© 2023 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.)
- Published
- 2024
- Full Text
- View/download PDF
23. Plaque-like cutaneous mucinosis in a patient with KRAS-mutated giant cell granuloma of the jaw.
- Author
-
Mattia A, Thompson A, Lee SJ, Richardson S, Guimarães LM, Gomes CC, Gomez RS, and Schaffer A
- Subjects
- Humans, Proto-Oncogene Proteins p21(ras) genetics, Skin, Granuloma, Giant Cell genetics, Skin Diseases genetics, Connective Tissue Diseases, Mucinoses diagnosis, Mucinoses genetics
- Published
- 2024
- Full Text
- View/download PDF
24. Should we consider sarcopenia in pediatric patients with chronic kidney disease? A preliminary cross-sectional analysis.
- Author
-
Barbosa ACC, Brison RS, Gomes CC, Wilkinson TJ, Duarte MP, Gruezo ND, and Ribeiro HS
- Subjects
- Male, Adolescent, Humans, Child, Female, Cross-Sectional Studies, Hand Strength, Anthropometry, Muscle Strength, Sarcopenia diagnosis, Sarcopenia epidemiology, Sarcopenia etiology, Renal Insufficiency, Chronic complications
- Abstract
Background: Pediatric patients with chronic kidney disease (CKD) frequently present an inadequate nutritional profile and musculoskeletal impairments. We investigated sarcopenia and its related traits in children and adolescents with CKD., Methods: A cross-sectional study that enrolled pediatric patients with CKD (≥ 4 and < 18 years old). Physical function was assessed by handgrip strength and the 60-s sit-to-stand (STS-60) tests. Body composition measurement was performed by bioelectrical impedance analysis and anthropometry through mid-upper arm circumference (MUAC). Normative reference values from healthy pediatrics were used for identifying poor physical function and low MUAC. Probable sarcopenia was considered as low handgrip strength, whereas sarcopenia was defined by adding low MUAC., Results: Twenty-two pediatric patients with CKD (11 ± 4 years and 59% boys) were evaluated; eight on peritoneal dialysis (36%), six on hemodialysis (27%), and eight non-dialysis (36%). Regarding sarcopenia traits, we observed low physical function by handgrip strength and STS-60 in 59% and 100% of the patients, respectively, while low MUAC in 77%. Probable sarcopenia was found in 9% and sarcopenia in 50%, but prevalence did not differ among stages. Handgrip strength was strongly associated with MUAC (r = 0.90; p < 0.001); on the other hand, the STS-60 was not significantly associated with any of the body composition variables., Conclusion: Among pediatric patients with CKD, the prevalence of sarcopenia and its related traits was high. Nephrology professionals should consider the assessment of sarcopenia in this population, while more evidence is needed to determine its prognostic value. A higher resolution version of the Graphical abstract is available as Supplementary information., (© 2023. The Author(s), under exclusive licence to International Pediatric Nephrology Association.)
- Published
- 2024
- Full Text
- View/download PDF
25. Comprehensive Genomic Analysis of Cemento-Ossifying Fibroma.
- Author
-
Gomez RS, El Mouatani A, Duarte-Andrade FF, Pereira TDSF, Guimarães LM, Gayden T, Faury D, Nakada EM, Langlois S, Sinnett D, de Castro WH, Diniz MG, Jabado N, and Gomes CC
- Subjects
- Humans, Genomics, Protein Tyrosine Phosphatases, Non-Receptor, Adaptor Proteins, Signal Transducing, Ubiquitin-Protein Ligases, Cementoma pathology, Fibroma, Ossifying genetics, Odontogenic Tumors pathology
- Abstract
Cemento-ossifying fibroma (COF) of the jaws is currently classified as a benign mesenchymal odontogenic tumor, and only targeted approaches have been used to assess its genetic alterations. A minimal proportion of COFs harbor CDC73 somatic mutations, and copy number alterations (CNAs) involving chromosomes 7 and 12 have recently been reported in a small proportion of cases. However, the genetic background of COFs remains obscure. We used a combination of whole-exome sequencing and RNA sequencing to assess somatic mutations, fusion transcripts, and CNAs in a cohort of 12 freshly collected COFs. No recurrent fusions have been identified among the 5 cases successfully analyzed by RNA sequencing, with in-frame fusions being detected in 2 cases (MARS1::GOLT1B and PARG::BMS1 in one case and NCLN::FZR1 and NFIC::SAMD1 in the other case) and no candidate fusions identified for the remaining 3 cases. No recurrent pathogenic mutations were detected in the 11 cases that had undergone whole-exome sequencing. A KRAS p.L19F missense variant was detected in one case, and 2 CDC73 deletions were detected in another case. The other variants were of uncertain significance and included variants in PC, ACTB, DOK6, HACE1, and COL1A2 and previously unreported variants in PTPN14, ATP5F1C, APOBEC1, HDAC5, ATF7IP, PARP2, and ACTR3B. The affected genes do not clearly converge on any signaling pathway. CNAs were detected in 5/11 cases (45%), with copy gains involving chromosome 12 occurring in 3/11 cases (27%). In conclusion, no recurrent fusions or pathogenic variants have been detected in the present COF cohort, with copy gains involving chromosome 12 occurring in 27% of cases., (Copyright © 2023 United States & Canadian Academy of Pathology. Published by Elsevier Inc. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
26. No BRAF p.V600E mutation detection in ameloblastoma liquid biopsy-based analysis by ddPCR.
- Author
-
Gomes IP, Miguita L, Gomes-Fernandes B, Coura BP, Castro WH, Carneiro JG, De Marco LA, Gomez RS, Bastos-Rodrigues L, and Gomes CC
- Subjects
- Humans, Liquid Biopsy, Polymerase Chain Reaction, Mutation, Proto-Oncogene Proteins B-raf genetics, Ameloblastoma diagnosis, Ameloblastoma genetics
- Abstract
Competing Interests: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
- Published
- 2024
- Full Text
- View/download PDF
27. Familial Melanoma Phenotype With Xeroderma Pigmentosum Group C (XP-C) Genotype - The Putative Role of MC1R Polymorphism as Modifier.
- Author
-
Leidenz FAB, Bittencourt FV, Braga WG, de Sá Araújo EM, Gomes CC, de Fatima Bernardes V, Friedman E, and De Marco L
- Abstract
Introduction: Xeroderma pigmentosum (XP), a rare inherited condition, hallmarked by extreme sensitivity to sun exposure resulting in multiple skin cancers and non-malignant skin alterations is attributed to homozygous inactivating pathogenic variants (PVs) in DNA repair genes, predominantly the XPC gene., Objectives: Report a unique phenotypic expression of mutant XPC allele that may be compatible with a putative modifier role for MC1R polymorphism., Methods: A family of 13 siblings, seven of whom were diagnosed with at least one cutaneous melanoma (N = 53) and non-melanoma skin cancers (N = 9) was studied. Of seven melanoma-affected cases, five consented for genetic analysis. CDKN2A revealed no PV in any case and subsequent whole-exome sequencing (WES) identified a rare homozygous missense PV (c.919C>T; p.Arg307Trp) in exon 8 of the XPC gene in all affected individuals. Notably, XPC PV carriers who co-harbored the p.I155T MC1R variant (N = 3) exhibited larger number of tumors, deeper Breslow indexes, higher rates of invasive melanomas and earlier age at diagnosis compared with non MC1R variant carriers (N = 2)., Conclusions: Familial malignant melanoma phenotype may, in fact, be an unusual clinical presentation of XPC, and MC1R may be a genetic modifier of penetrance and phenotype of mutant XPC alleles.
- Published
- 2024
- Full Text
- View/download PDF
28. The altered metabolic pathways of diffuse large B-cell lymphoma not otherwise specified.
- Author
-
Rodrigues-Fernandes CI, Martins-Chaves RR, Vitório JG, Duarte-Andrade FF, Pereira TDSF, Soares CD, Moreira VR, Lebron YAR, Santos LVS, Lange LC, Canuto GAB, Gomes CC, de Macedo AN, Pontes HAR, Burbano RMR, Martins MD, Pires FR, Mesquita RA, Gomez RS, Santos-Silva AR, Lopes MA, Vargas PA, and Fonseca FP
- Subjects
- Humans, B-Lymphocytes metabolism, Germinal Center metabolism, Metabolic Networks and Pathways, Prognosis, Biomarkers, Tumor metabolism, Lymphoma, Large B-Cell, Diffuse pathology
- Abstract
Altered metabolic fingerprints of Diffuse large B-cell lymphoma, not otherwise specified (DLBCL NOS) may offer novel opportunities to identify new biomarkers and improve the understanding of its pathogenesis. This study aimed to investigate the modified metabolic pathways in extranodal, germinal center B-cell (GCB) and non-GCB DLBCL NOS from the head and neck. Formalin-fixed paraffin-embedded (FFPE) tissues from eleven DLBCL NOS classified according to Hans' algorithm using immunohistochemistry, and five normal lymphoid tissues (LT) were analyzed by high-performance liquid chromatography-mass spectrometry-based untargeted metabolomics. Partial Least Squares Discriminant Analysis showed that GCB and non-GCB DLBCL NOS have a distinct metabolomics profile, being the former more similar to normal lymphoid tissues. Metabolite pathway enrichment analysis indicated the following altered pathways: arachidonic acid, tyrosine, xenobiotics, vitamin E metabolism, and vitamin A. Our findings support that GCB and non-GCB DLBCL NOS has a distinct metabolomic profile, in which GCB possibly shares more metabolic similarities with LT than non-GCB DLBCL NOS.
- Published
- 2023
- Full Text
- View/download PDF
29. DNA methylation profile discriminates sporadic giant cell granulomas of the jaws and cherubism from their giant cell-rich histological mimics.
- Author
-
Guimarães LM, Baumhoer D, Andrei V, Friedel D, Koelsche C, Gomez RS, von Deimling A, and Gomes CC
- Subjects
- Humans, DNA Methylation, Giant Cells pathology, Jaw pathology, Cherubism diagnosis, Cherubism genetics, Cherubism pathology, Granuloma, Giant Cell diagnosis, Granuloma, Giant Cell genetics, Granuloma, Giant Cell pathology, Chondroblastoma diagnosis, Chondroblastoma genetics, Chondroblastoma pathology, Giant Cell Tumor of Bone diagnosis, Giant Cell Tumor of Bone genetics, Giant Cell Tumor of Bone pathology, Bone Neoplasms diagnosis, Bone Neoplasms genetics, Bone Neoplasms pathology
- Abstract
Sporadic giant cell granulomas (GCGs) of the jaws and cherubism-associated giant cell lesions share histopathological features and microscopic diagnosis alone can be challenging. Additionally, GCG can morphologically closely resemble other giant cell-rich lesions, including non-ossifying fibroma (NOF), aneurysmal bone cyst (ABC), giant cell tumour of bone (GCTB), and chondroblastoma. The epigenetic basis of these giant cell-rich tumours is unclear and DNA methylation profiling has been shown to be clinically useful for the diagnosis of other tumour types. Therefore, we aimed to assess the DNA methylation profile of central and peripheral sporadic GCG and cherubism to test whether DNA methylation patterns can help to distinguish them. Additionally, we compared the DNA methylation profile of these lesions with those of other giant cell-rich mimics to investigate if the microscopic similarities extend to the epigenetic level. DNA methylation analysis was performed for central (n = 10) and peripheral (n = 10) GCG, cherubism (n = 6), NOF (n = 10), ABC (n = 16), GCTB (n = 9), and chondroblastoma (n = 10) using the Infinium Human Methylation EPIC Chip. Central and peripheral sporadic GCG and cherubism share a related DNA methylation pattern, with those of peripheral GCG and cherubism appearing slightly distinct, while central GCG shows overlap with both of the former. NOF, ABC, GCTB, and chondroblastoma, on the other hand, have distinct methylation patterns. The global and enhancer-associated CpG DNA methylation values showed a similar distribution pattern among central and peripheral GCG and cherubism, with cherubism showing the lowest and peripheral GCG having the highest median values. By contrast, promoter regions showed a different methylation distribution pattern, with cherubism showing the highest median values. In conclusion, DNA methylation profiling is currently not capable of clearly distinguishing sporadic and cherubism-associated giant cell lesions. Conversely, it could discriminate sporadic GCG of the jaws from their giant cell-rich mimics (NOF, ABC, GCTB, and chondroblastoma)., (© 2023 The Authors. The Journal of Pathology: Clinical Research published by The Pathological Society of Great Britain and Ireland and John Wiley & Sons Ltd.)
- Published
- 2023
- Full Text
- View/download PDF
30. Can SARS-CoV-2 screening in oral biopsies aid epidemiological surveillance?
- Author
-
Martins-Chaves RR, Diniz MG, Miguita L, Felix FA, Rocha FF, Fonseca PLC, Geddes VEV, Menezes D, Moreira RG, Liborio-Kimura T, Câmara J, da Costa Mendes TC, Pontes HAR, Pontes FSC, de Freitas Gonçalves TO, Fonsêca TC, Abrahão AC, Romañach MJ, Alves APNN, Pereira KMA, da Cruz Perez DE, de Amorim Carvalho EJ, Dos Santos JN, de Aquino Xavier FC, Giffoni FC, de Souza AH, Gomes CC, de Sousa SF, Fonseca FP, de Souza RP, Aguiar RS, and Gomez RS
- Subjects
- Humans, Phylogeny, Pandemics, SARS-CoV-2 genetics, COVID-19 diagnosis, COVID-19 epidemiology
- Abstract
Background: Three years after the first confirmed COVID-19 case in Brazil, the outcomes of Federal government omissions in managing the crisis and anti-science stance heading into the pandemic have become even more evident. With over 36 million confirmed cases and nearly 700 000 deaths up to January 2023, the country is one of the hardest-hit places in the world. The lack of mass-testing programs was a critical broken pillar responsible for the quick and uncontrolled SARS-CoV-2 spread throughout the Brazilian population. Faced with this situation, we aimed to perform the routine SARS-CoV-2 screening through RT-qPCR of oral biopsies samples to aid in the asymptomatic epidemiological surveillance during the principal outbreak periods., Methods: We analyzed 649 formalin-fixed paraffin-embedded oral tissue samples from five important oral and maxillofacial pathology laboratories from the north, northeast, and southeast geographic regions of Brazil. We also sequenced the whole viral genome of positive cases to investigate SARS-CoV-2 variants., Results: The virus was detected in 9/649 analyzed samples, of which three harbored the Variant of Concern Alpha (B.1.1.7)., Conclusion: Although our approach did not value aiding asymptomatic epidemiological surveillance, we could successfully identify a using FFPE tissue samples. Therefore, we suggest using FFPE tissue samples from patients who have confirmed diagnosis of SARS-CoV-2 infection for phylogenetic reconstruction and contraindicate the routine laboratory screening of these samples as a tool for asymptomatic epidemiological surveillance., (© 2023 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.)
- Published
- 2023
- Full Text
- View/download PDF
31. Fusion genes aiding the diagnosis of soft tissue tumours of the oral cavity: From bench to bedside.
- Author
-
Gomes IP, Guimarães LM, Gomez RS, and Gomes CC
- Subjects
- Humans, Translocation, Genetic, Gene Rearrangement, Mouth pathology, Sarcoma diagnosis, Soft Tissue Neoplasms diagnosis, Soft Tissue Neoplasms genetics, Soft Tissue Neoplasms pathology
- Abstract
Soft tissue tumours (STT) are a heterogeneous group of benign, malignant, and intermediate/borderline mesenchymal tumours. In the oral and maxillofacial region, less than 3% of all lesions correspond to benign STT and <1% are sarcomas. Overlapping microscopic features may lead to quite challenging diagnostic processes. Translocations and fusion genes are frequent, and type-specific genetic alterations are detected in these tumours. The detection of such alterations by classic cytogenetic, FISH, RT-PCR or NGS can help to define the diagnosis. This narrative review aims to review fusion genes reported for STT that affect the oral cavity and their use in diagnostic molecular pathology. Basic concepts regarding mechanisms of fusion genes formation are presented to clarify this information for surgical pathologists. The chromosomal rearrangements and fusion genes of adipocytic, fibroblastic and myofibroblastic, vascular, pericytic, smooth muscle, skeletal muscle, chondro-osseous, and uncertain origin STT are summarised. The advance in molecular pathology techniques has led not only to a better understanding of the molecular pathogenesis of STT, but also to the development of helpful diagnostic tools. Therefore, it is important for the oral and head and neck pathologists to familiarise with the signature rearrangements and fusion genes for each tumour., (© 2023 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.)
- Published
- 2023
- Full Text
- View/download PDF
32. No NFATC2 fusion in simple bone cyst of the jaw.
- Author
-
Ong SLM, Gomes IP, Baelde HJ, Passador-Santos F, de Andrade BAB, Briaire-de Bruijn IH, Cavalcante IL, Schreuder WH, Cleton-Jansen AM, Cleven AHG, Szuhai K, Gomes CC, and Bovée JVMG
- Subjects
- Humans, Bone Cysts genetics, Odontogenic Tumors genetics, NFATC Transcription Factors genetics
- Abstract
Aims: Simple Bone Cysts (SBCs) predominantly occur in long bones and 59% harbour NFATC2 rearrangements. Jaw SBC is rare and was previously referred to as traumatic bone cyst. It can rarely occur in association with cemento-osseous dysplasia (COD). To determine whether jaw SBCs represent the same entity as SBC of the long bones, or if they have a different molecular signature, we collected 48 jaw SBC cases of 47 patients to assess NFATC2 rearrangement., Methods and Results: Out of the 48 cases, 36 could be used for fluorescence in-situ hybridization (FISH), of which nine (two of which associated with COD) were successful using an NFATC2 split probe. The remaining cases failed to show adequate FISH signals. All nine cases lacked NFATC2 rearrangement and five of these showed no detectable gene fusions using Archer FusionPlex., Conclusion: In our study, NFATC2 rearrangement is absent in solitary jaw SBC (n = 7) and COD-associated SBC (n = 2). Our findings suggest that SBC presenting in the jaw is molecularly different from SBC in long bones. Future molecular studies may confirm the absence of clonal molecular aberrations in SBC of the jaw which would support a non-neoplastic, reactive origin., (© 2023 The Authors. Histopathology published by John Wiley & Sons Ltd.)
- Published
- 2023
- Full Text
- View/download PDF
33. Analysis of KRAS, BRAF, and EGFR mutational status in respiratory epithelial adenomatoid hamartoma (REAH).
- Author
-
Guimarães LM, Vieira TDS, De Marco LA, Thompson LDR, and Gomes CC
- Subjects
- Humans, Proto-Oncogene Proteins B-raf genetics, Proto-Oncogene Proteins p21(ras) genetics, Respiratory Mucosa pathology, ErbB Receptors genetics, Diagnosis, Differential, Adenoma pathology, Hamartoma genetics, Hamartoma diagnosis, Hamartoma pathology
- Abstract
Background: Respiratory epithelial adenomatoid hamartoma (REAH) is a sinonasal glandular overgrowth arising from the surface respiratory epithelium and invaginating into the stroma. Clinically, it appears as a polypoid mass that may cause nasal obstruction, anosmia, and epistaxis. The presence of cartilaginous and/or osseous areas move the lesion to a chondro-osseous respiratory epithelial (CORE) hamartoma subtype. Scattered small seromucinous glands may be observed between typical REAH glands and when it is the only feature, it represents seromucinous hamartoma (SH). The molecular pathogenesis of REAH has been poorly explored and remains unclear. Given that KRAS, BRAF, and EGFR mutations have been detected in a variety of sinonasal tumors, we aimed to assess these mutations in REAH and SH., Methods: Ten REAH (including one CORE subtype), in addition to two SH cases, were Sanger sequenced by standard techniques. The targeted regions included KRAS exons 2-4 (encompassing hotspots codons 12, 13, 61, and 146), BRAF exons 11 and 15 (spanning the V600 codon), and EGFR exons 19 and 20., Results: All REAH and SH samples showed wild-type sequences for KRAS, BRAF, and EGFR genes., Conclusion: Our results demonstrate a lack of KRAS, BRAF, or EGFR pathogenic variants with further evaluation of REAH and SH needed to elucidate driver genetic events., (© 2022 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.)
- Published
- 2023
- Full Text
- View/download PDF
34. New approaches concerning the testis of Astyanax lacustris (Characidae): immunohistochemical studies.
- Author
-
Costa FG, Gomes CC, Adolfi MC, da Cruz Gallo de Carvalho MC, Zanoni MA, Seiva FRF, and Borella MI
- Subjects
- Male, Animals, Fibronectins analysis, Receptors, Androgen analysis, Laminin analysis, Actins, Collagen Type I, Claudin-1 analysis, Keratins analysis, Testis, Characidae
- Abstract
Astyanax lacustris, locally known as lambari-do-rabo-amarelo, is a study model for Neotropical fish. Testis of A. lacustris shows deep morphophysiological changes throughout the annual reproductive cycle. This work analyzed the distribution of claudin-1, actin, and cytokeratin as elements of the cytoskeleton in germinal epithelium and interstitium; the distribution of type I collagen, fibronectin, and laminin as extracellular matrix compounds; and the localization of androgen receptor in the testis of this species. Claudin-1, cytokeratin, and actin were present in the Sertoli cells and modified Sertoli cells, and actin was also detected in peritubular myoid cells. Type I collagen were in the interstitial tissue, laminin in the basement membrane of germinal epithelium and endothelium, but fibronectin was additionally detected in the germinal epithelium compartment. The labeling of androgen receptor was higher in peritubular myoid cells and undifferentiated spermatogonia, and weaker labeling was detected in type B spermatogonia. Therefore, the present work highlights new aspects of the biology of the testis of A. lacustris, and contribute to amplify the understanding of this organ., (© 2023. The Author(s), under exclusive licence to Springer Nature B.V.)
- Published
- 2023
- Full Text
- View/download PDF
35. Chronic rhinosinusitis with nasal polyps does not harbor KRAS, BRAF, and EGFR mutations.
- Author
-
da Silva Vieira T, Guimarães LM, Diniz MG, Gomes-Fernandes B, Anselmo-Lima WT, Tamashiro E, Bastos-Rodrigues L, De Marco L, Gomez RS, Valera FCP, and Gomes CC
- Subjects
- Humans, Proto-Oncogene Proteins B-raf genetics, Proto-Oncogene Proteins p21(ras) genetics, Quality of Life, Mutation, Squamous Cell Carcinoma of Head and Neck, Inflammation, ErbB Receptors genetics, Chronic Disease, Nasal Polyps complications, Nasal Polyps genetics, Sinusitis complications, Sinusitis genetics, Head and Neck Neoplasms, Papilloma genetics
- Abstract
Background: Chronic rhinosinusitis is a chronic inflammation of the nasal mucosa and nasal polyps are present in ~25%-30% of cases (chronic rhinosinusitis with nasal polyps [CRSwNP]). CRSwNP is associated with significant morbidity and decreased quality of life, making it clinically important. Inflammation leads to DNA damage and DNA mutations occur in some inflammatory diseases. Notably, mutations in KRAS, BRAF, and EGFR have been reported in different human benign and malignant neoplastic lesions. In addition, KRAS mutations have also been reported in non-neoplastic tissues under chronic inflammatory conditions. Importantly, KRAS mutations have been reported in oncocytic sinonasal papillomas and sinonasal squamous cell carcinoma associated with oncocytic sinonasal papilloma and EGFR mutations have been reported in sinonasal adenocarcinoma, inverted sinonasal papilloma, and sinonasal squamous cell carcinoma associated with inverted sinonasal papilloma. The molecular pathogenesis of nasal polyps remains unclear. Therefore, the present study aimed to investigate the presence of KRAS, BRAF, and EGFR pathogenic mutations in CRSwNP., Methods: Fourteen chronic rhinosinusitis-associated nasal polyp samples were direct sequenced, targeting KRAS exons 2, 3, and 4 (encompassing important hotspot mutations, including codons 12, 13, 61 and 146), BRAF exons 11 and 15, and EGFR exons 19 and 20., Results: No pathogenic mutations were detected in the sequenced regions of KRAS, BRAF, and EGFR genes., Conclusion: This finding suggests that mutations in these genes are not a frequent event in CRSwNP, and, if they occur, they might represent marginal events at best., (© 2022 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.)
- Published
- 2023
- Full Text
- View/download PDF
36. Dental effects associated with benign odontogenic tumors in young individuals: A meta-analysis.
- Author
-
Freitas LC, Viana KSS, Guimarães Abreu L, Gomes CC, and Bernardes VF
- Subjects
- Humans, Odontogenic Tumors pathology
- Published
- 2023
- Full Text
- View/download PDF
37. Adenoid Ameloblastoma vs Dentinogenic Ghost Cell Tumor: Are They Related Entities?
- Author
-
Bastos VC, Guimarães LM, Gomes CC, and Gomez RS
- Subjects
- Humans, Neoplasm Recurrence, Local pathology, Ameloblastoma pathology, Adenoids pathology, Odontogenic Tumors pathology
- Published
- 2023
- Full Text
- View/download PDF
38. The molecular basis of odontogenic cysts and tumours.
- Author
-
Gomes IP, Bastos VC, Guimarães LM, and Gomes CC
- Subjects
- Humans, Proto-Oncogene Proteins B-raf genetics, Ameloblastoma genetics, Ameloblastoma pathology, Odontogenic Tumors pathology, Odontogenic Cysts pathology, Odontoma pathology, Mouth Neoplasms, Carcinoma
- Abstract
The advances in molecular technologies have allowed a better understanding of the molecular basis of odontogenic cysts and tumours. PTCH1 mutations have been reported in a high proportion of odontogenic keratocyst. BRAF p.V600E are recurrent in ameloblastoma and KRAS p.G12V/R in adenomatoid odontogenic tumour, dysregulating the MAPK/ERK pathway. Notably, BRAF p.V600E is also detected in ameloblastic carcinoma, but at a lower frequency than in its benign counterpart ameloblastoma. Recently, adenoid ameloblastoma has been shown to be BRAF wild-type and to harbour CTNNB1 (β-catenin gene) mutations, further suggesting that it is not an ameloblastoma subtype. CTNNB1 mutations also occur in other ghost-cell-containing tumours, including calcifying odontogenic cysts, dentinogenic ghost cell tumours and odontogenic carcinoma with dentinoid, but the link between CTNNB1 mutations and ghost cell formation in these lesions remains unclear. Regarding mixed tumours, BRAF p.V600E has been reported in a subset of ameloblastic fibromas, ameloblastic-fibrodentinomas and fibro-odontomas, in addition to ameloblastic fibrosarcoma. Such mutation-positivity in a subset of samples can be helpful in differentiating some of these lesions from odontoma, which is BRAF-wild-type. Recently, FOS rearrangements have been reported in cementoblastoma, supporting its relationship with osteoblastoma. Collectively, the identification of recurrent mutations in these aforementioned lesions has helped to clarify their molecular basis and to better understand the interrelationships between some tumours, but none of these genetic abnormalities is diagnostic. Since the functional effect of pathogenic mutations is context and tissue-dependent, a clear role for the reported mutations in odontogenic cysts and tumours in their pathogenesis remains to be elucidated., (© 2023 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.)
- Published
- 2023
- Full Text
- View/download PDF
39. Single substitution in H3.3G34 alters DNMT3A recruitment to cause progressive neurodegeneration.
- Author
-
Khazaei S, Chen CCL, Andrade AF, Kabir N, Azarafshar P, Morcos SM, França JA, Lopes M, Lund PJ, Danieau G, Worme S, Adnani L, Nzirorera N, Chen X, Yogarajah G, Russo C, Zeinieh M, Wong CJ, Bryant L, Hébert S, Tong B, Sihota TS, Faury D, Puligandla E, Jawhar W, Sandy V, Cowan M, Nakada EM, Jerome-Majewska LA, Ellezam B, Gomes CC, Denecke J, Lessel D, McDonald MT, Pizoli CE, Taylor K, Cocanougher BT, Bhoj EJ, Gingras AC, Garcia BA, Lu C, Campos EI, Kleinman CL, Garzia L, and Jabado N
- Subjects
- Animals, Mice, DNA (Cytosine-5-)-Methyltransferases genetics, DNA Methylation genetics, DNA Modification Methylases genetics, Neuroinflammatory Diseases, DNA Methyltransferase 3A, Histones metabolism
- Abstract
Germline histone H3.3 amino acid substitutions, including H3.3G34R/V, cause severe neurodevelopmental syndromes. To understand how these mutations impact brain development, we generated H3.3G34R/V/W knock-in mice and identified strikingly distinct developmental defects for each mutation. H3.3G34R-mutants exhibited progressive microcephaly and neurodegeneration, with abnormal accumulation of disease-associated microglia and concurrent neuronal depletion. G34R severely decreased H3K36me2 on the mutant H3.3 tail, impairing recruitment of DNA methyltransferase DNMT3A and its redistribution on chromatin. These changes were concurrent with sustained expression of complement and other innate immune genes possibly through loss of non-CG (CH) methylation and silencing of neuronal gene promoters through aberrant CG methylation. Complement expression in G34R brains may lead to neuroinflammation possibly accounting for progressive neurodegeneration. Our study reveals that H3.3G34-substitutions have differential impact on the epigenome, which underlie the diverse phenotypes observed, and uncovers potential roles for H3K36me2 and DNMT3A-dependent CH-methylation in modulating synaptic pruning and neuroinflammation in post-natal brains., Competing Interests: Declaration of interests The authors declare no competing interests., (Copyright © 2023 Elsevier Inc. All rights reserved.)
- Published
- 2023
- Full Text
- View/download PDF
40. Adenoid Ameloblastoma Versus Dentinogenic Ghost Cell Tumor.
- Author
-
Bastos VC, Gomes CC, and Gomez RS
- Subjects
- Humans, Diagnosis, Differential, Head pathology, Ameloblastoma pathology, Odontogenic Tumors pathology, Adenoids pathology
- Abstract
Background: A recent systematic review published in Head and Neck Pathology found that 3.8% of dentinogenic ghost cell tumors harbor duct-like/ cribriform architecture. Herein we discuss this finding regarding the differential diagnosis of this tumor with adenoid ameloblastoma., Methods: A critical review of some microscopic findings reported in a recent paper published in the Head and Neck Pathology Journal was done., Results: Although there are overlapping microscopic features with dentinogenic ghost cell tumor, adenoid ameloblastoma is distinguished by the combination of duct-like structures and whorls/morules. In our opinion, at least some cases previously diagnosed as dentinogenic ghost cell tumors may now be more accurately classified as adenoid ameloblastoma., Conclusion: We conclude that a reassessment of dentinogenic ghost cell tumor cases using the diagnostic criteria proposed by the new WHO classification of Head and Neck Tumors (2022) is warranted., (© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.)
- Published
- 2023
- Full Text
- View/download PDF
41. A new TRPV4 mutation in a case of multiple central giant cell granulomas of the jaws.
- Author
-
Guimarães LM, Martins-Chaves RR, Chabot PQ, Schreuder WH, de Castro WH, Gomez RS, and Gomes CC
- Subjects
- Male, Humans, Adolescent, TRPV Cation Channels genetics, Proto-Oncogene Proteins p21(ras) genetics, Mutation genetics, Jaw pathology, Granuloma, Giant Cell genetics
- Abstract
Sporadic central giant cell granulomas of the jaws (GCGJ) are often solitary lesions, characterized by KRAS, FGFR1, and TRPV4 somatic mutations. Multifocal lesions may occur and are associated with hyperparathyroidism or underlying syndromes such as cherubism, which is marked by SH3BP2 mutations, and RASopathies, which are caused by mutations in the FGFR-RAS-RAF-MEK-ERK signaling cascade. The diagnosis of multiple GCGJ can be challenging. The present case reports a 14-year-old boy with multiple central GCGJ and no obvious syndromic trait. Sanger sequencing-based analysis revealed wild-type sequences for SH3BP2 (exon 9), KRAS (exons 2-4), and FGFR1 (exons 9 and 10) genes. A rare TRPV4 somatic mutation (p.Val708Met) was detected in the lesion on the right side of the mandible, whereas the other tumor and the normal oral mucosa revealed wild-type TRPV4 sequences. This report expands the spectrum of TRPV4 somatic mutations in central GCGJ., (Copyright © 2022 Elsevier Inc. All rights reserved.)
- Published
- 2023
- Full Text
- View/download PDF
42. Interrogation of TERT promoter hotspot mutations in ameloblastoma and ameloblastic carcinoma.
- Author
-
Magalhães MCSV, Felix FA, Guimarães LM, Dos Santos JN, de Marco LA, Gomez RS, Gomes CC, and de Sousa SF
- Subjects
- Humans, Mutation, Ameloblastoma genetics, Telomerase genetics, Telomerase metabolism, Odontogenic Tumors genetics, Carcinoma
- Abstract
Background: TERT promoter mutations increase telomerase activity, conferring cell immortality. The coexistence of TERT promoter mutations with BRAFV600E is associated with aggressiveness. Ameloblastoma and ameloblastic carcinoma are infiltrative neoplasms that harbor BRAFV600E; however, it remains unknown if these odontogenic tumors also show TERT promoter mutations., Methods: Genomic DNA of paraffin-embedded ameloblastomas (n = 6) and ameloblastic carcinomas (n = 3) were Sanger-sequenced to assess the hotspot TERT promoter mutations C228T and C250T. BRAFV600E status was screened by TaqMan allele-specific quantitative polymerase chain reaction., Results: None of the samples harbored TERT promoter mutations. The BRAFV600E mutation was positive in 3 of 6 of ameloblastomas and in 1 of 3 of ameloblastic carcinomas., Conclusion: The absence of TERT promoter mutation in the samples indicates that this molecular event is not relevant to the tumors' pathogenesis. Further studies are necessary to explore undefined genetic or epigenetic mechanisms related to TERT-upregulation in ameloblastoma, and the telomerase activity in ameloblastic carcinoma., (© 2022 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.)
- Published
- 2023
- Full Text
- View/download PDF
43. Nanotechnology as a Tool for Optimizing Topical Photoprotective Formulations Containing Buriti Oil ( Mauritia flexuosa ) and Dry Aloe vera Extracts: Stability and Cytotoxicity Evaluations.
- Author
-
Reis-Mansur MCPP, Firmino Gomes CC, Nigro F, Ricci-Júnior E, de Freitas ZMF, and Dos Santos EP
- Abstract
Human beings are actively exposed to ultraviolet (UV) radiation, which is associated with skin cancer. This has encouraged the continuous search for more effective and safer photoprotective formulations. Along with the application of traditional organic sunscreens, there is a growing interest in "green products" containing natural compounds such as plant extracts and oils. This trend is combined with the use of nanotechnology as a tool for optimizing the vehicles of such compounds. Nanoemulsions (NEs) are suitable for the encapsulation of natural compounds, which improves topical treatment. Therefore, we have developed oil-in-water (O/W) nanoemulsions containing 3% buriti oil (BO), incorporated in a 10% vegetal extract of Aloe vera (AV) by means of ultrasonic processing to improve the chemical characteristics of this component and, consequently, its efficacy and safety in pharmaceutical and cosmetic formulations. The composition of the formulation was initially defined in a preliminary study on surfactants where the concentrations of Tween
® 80 and Span® 20 were evaluated in relation to particle size and the polydispersity index (PDI). The nanoemulsion was prepared and then chemical sunscreens were incorporated with the aim of developing a sunscreen nanoemulsion called NE-A19. This nanoemulsion was found to be the best formulation due to its stability, droplet size (146.80 ± 2.74), and PDI (0.302 ± 0.088), with a monomodal size distribution. The stability was evaluated over 90 days and showed a low growth in particle size at the end of the study. NE-A19 exhibited good viscosity and organoleptic properties, in addition to an occlusion factor indicating an interesting and higher water holding capacity when compared with a NE without AV ( p < 0.05). The in vitro efficacy and safety studies of NE-19A were promising. Its average in vitro sun protection factor value was 49, with a critical wavelength (λc ) of 369.7 nm, satisfactory UVA protection, and a UVA/UVB ratio of 0.40, indicating broad spectrum protection against UVA and UVB radiation. Furthermore, NE-19A displayed a good safety profile in dermal keratinocytes. It can be concluded that NE-19A is a promising formulation for carrying natural products, such as buriti oil and AV, associated with synthetic filters in lower concentrations.- Published
- 2023
- Full Text
- View/download PDF
44. Evaluation of Receptor Activator of Nuclear Factor Kappa B Ligand, Osteoprotegerin, Osteopontin, and Tumor Necrosis Factor Alpha on Chronic Apical Periodontitis in Smokers.
- Author
-
de Paula KM, Gomes CC, Valente MIB, Pires FR, Batistela Rodrigues Thuller KA, Salles L, and Armada L
- Subjects
- Humans, Adolescent, Infant, Osteoprotegerin metabolism, Tumor Necrosis Factor-alpha, Smokers, RANK Ligand metabolism, NF-kappa B, Osteopontin, Periodontitis, Periapical Periodontitis metabolism
- Abstract
Introduction: Smoking can be considered a risk factor for chronic apical periodontitis (CAP). This study compared the immunoexpression of biomarkers receptor activator of nuclear factor kappa B ligand (RANKL), osteoprotegerin (OPG), osteopontin (OPN), and tumor necrosis factor alpha (TNF-α) in CAP in smokers and nonsmokers., Methods: Twelve smokers and 12 nonsmokers diagnosed with CAP and indicated for tooth extraction were selected. Exclusion factors were teeth with a diagnosis of root fracture, previous endodontic treatment, or endoperiodontal injury, in addition to individuals with systemic diseases, under 18 years of age, users of anti-inflammatory and/or antibiotics in the last 3 months, and drug users. Specimens were processed for histopathologic and immunohistochemical analysis., Results: Qualitative analysis of RANKL expression showed 66.66% weak/moderate and 33.33% strong in smokers and 100% weak/moderate in nonsmokers. OPG and OPN expressions were 100% negative to focal in the smoker group and 50% negative to focal and 50% weak/moderate in the nonsmoker group. TNF-α was 25% negative to focal and 75% weak/moderate in the smoker group and 33.33% negative to focal and 66.66% weak/moderate in the nonsmoker group. Quantitative analysis of the data using the Mann-Whitney U test showed that there was a significant difference in the immunoexpression of RANKL (P < .05), OPG (P < .05), and OPN (P < .05), but there was no statistical difference in the immunoexpression of TNF-α (P > .05) between the 2 groups., Conclusions: These findings suggest that smoking is capable of altering the inflammatory response, influencing the evolution of CAP., (Copyright © 2022 American Association of Endodontists. Published by Elsevier Inc. All rights reserved.)
- Published
- 2023
- Full Text
- View/download PDF
45. A radiolucency in the posterior mandible.
- Author
-
Bastos VC, Fraga MG, Cunha JF, Gomes CC, Mesquita RA, Fonseca FP, and Gomez RS
- Subjects
- Humans, Diagnosis, Differential, Mandible diagnostic imaging, Mandibular Neoplasms diagnostic imaging, Mandibular Neoplasms surgery
- Published
- 2023
- Full Text
- View/download PDF
46. Adenoid ameloblastoma harbors beta-catenin mutations.
- Author
-
Bastos VC, Coura BP, Guimarães LM, Fernandes BG, Chan AC, Vargas PA, Bastos-Rodrigues L, De Marco LA, Hellstein J, Thavaraj S, Wright JM, Odell EW, Gomez RS, and Gomes CC
- Subjects
- Humans, Male, Female, beta Catenin genetics, beta Catenin metabolism, Proto-Oncogene Proteins B-raf genetics, Proto-Oncogene Proteins p21(ras) genetics, Proto-Oncogene Proteins p21(ras) metabolism, Mutation, Ameloblastoma genetics, Ameloblastoma pathology, Adenoids metabolism, Adenoids pathology, Odontogenic Tumors pathology
- Abstract
Adenoid ameloblastoma is a very rare benign epithelial odontogenic tumor characterized microscopically by epithelium resembling conventional ameloblastoma, with additional duct-like structures, epithelial whorls, and cribriform architecture. Dentinoid deposits, clusters of clear cells, and ghost-cell keratinization may also be present. These tumors do not harbor BRAF or KRAS mutations and their molecular basis appears distinct from conventional ameloblastoma but remains unknown. We assessed CTNNB1 (beta-catenin) exon 3 mutations in a cohort of 11 samples of adenoid ameloblastomas from 9 patients. Two of the 9 patients were female and 7 male and in 7/9 patients the tumors occurred in the maxilla. Tumors of 4 of these 9 patients harbored CTNNB1 mutations, specifically p.Ser33Cys, p.Gly34Arg, and p.Ser37Phe. Notably, for one patient 3 samples were analyzed including the primary tumour and two consecutive recurrences, and results were positive for the mutation in all three tumors. Therefore, 6/11 samples tested positive for the mutation. In the 6 mutation-positive samples, ghost cells were present in only 2/6, indicating beta-catenin mutations are not always revealed by ghost cell formation. Dentinoid matrix deposition was observed in 5/6 mutation-positive samples and clear cells in all 6 cases. None of the cases harbored either BRAF or KRAS mutations. Beta-catenin immunoexpression was assessed in the samples of 8 patients. Except for one wild-type case, all cases showed focal nuclear expression irrespective of the mutational status. Together with the absence of BRAF mutation, the detection of beta-catenin mutation in adenoid ameloblastomas supports its classification as a separate entity, and not as a subtype of ameloblastoma. The presence of this mutation may help in the diagnosis of challenging cases., (© 2022. The Author(s), under exclusive licence to United States & Canadian Academy of Pathology.)
- Published
- 2022
- Full Text
- View/download PDF
47. Unveiling metabolic changes in marsupialized odontogenic keratocyst: A pilot study.
- Author
-
Leite-Lima F, Bastos VC, Vitório JG, Duarte-Andrade FF, Pereira TDSF, Martins-Chaves RR, Cruz AF, de Lacerda JCT, Lebron YAR, Moreira VR, Santos LVS, Lange LC, de Macedo AN, Diniz MG, Gomes CC, de Castro WH, Canuto GAB, and Gomez RS
- Subjects
- Formaldehyde, Humans, Pilot Projects, Odontogenic Cysts pathology, Odontogenic Cysts surgery, Odontogenic Tumors
- Abstract
Objective: We aimed to assess which metabolic pathways would be implicated in the phenotypic changes of the epithelial lining of odontogenic keratocyst after marsupialization, comparing pre- and post-marsupialized lesions with adjacent oral mucosa., Materials and Methods: Eighteen formalin-fixed and paraffin-embedded tissues from six subjects were divided into three paired groups: odontogenic keratocyst pre- (n = 6) and post-marsupialization (n = 6), and adjacent oral mucosa (n = 6). The metabolic pathways found in these groups were obtained by high-performance liquid chromatography-mass spectrometry-based untargeted metabolomics performed., Results: Through putative metabolite annotation followed by pathway enrichment and predictive analysis with automated algorithms (Mummichog and Gene Set Enrichment Analysis), we found differences in many cellular processes that may be involved in inflammation, oxidative stress response, keratinocyte-basal membrane attachment, differentiation, and proliferation functions, all relevant to odontogenic keratocyst pathobiology and the phenotype acquired after marsupialization., Conclusion: Our study was able to identify several metabolic pathways potentially involved in the metaplastic changes induced by marsupialization of odontogenic keratocysts. An improved comprehension of this process could pave the way for the development of targeted therapies., (© 2021 Wiley Periodicals LLC.)
- Published
- 2022
- Full Text
- View/download PDF
48. SARS-CoV-2 infection prevalence and associated factors: a serial population-based study in Espírito Santo, Brazil, May to June 2020.
- Author
-
Cardoso OA, Gomes CC, Cerutti Junior C, Maciel ELN, Alencar FEC, Almada GL, Macedo LR, Silva LT, Medeiros Junior NF, Jabor PM, Zanotti RL, Reuter T, Andrade VLG, Bastos WM, and Zandonade E
- Subjects
- Brazil epidemiology, Cross-Sectional Studies, Humans, Prevalence, SARS-CoV-2, Seroepidemiologic Studies, COVID-19 epidemiology
- Abstract
Objective: To analyze SARS-CoV-2 seroprevalence and association of sociodemographic and clinical aspects in the state of Espírito Santo, Brazil., Methods: This was a serial cross-sectional study carried out in four phases, using households as the unit of analysis, from May to June 2020. Eleven municipalities were surveyed, with a sample of 4,500 households in each phase., Results: Prevalence ranged from 2.1% (95%CI 1.7;2.5) on May 10 (first phase) to 9.6% (95%CI 8.8;10.4) on June 21 (fourth phase). In the Greater Vitória Metropolitan Region, the prevalence were 2.7% (95%CI 2.2;3.3) in the first phase, and 11.5% (95%CI 10.5;12.6) in the fourth phase; in the interior region of the state, prevalence ranged from 0.4% (95%CI 0.1;0.9) to 4.4% (95%CI 3.2;5.5) between the two phases., Conclusion: The increase in SARS-CoV-2 seroprevalence found in the fourth phase highlighted the high transmission of the virus, information that can support management of the pandemic.
- Published
- 2022
- Full Text
- View/download PDF
49. Integrated proteomics, phosphoproteomics and metabolomics analyses reveal similarities among giant cell granulomas of the jaws with different genetic mutations.
- Author
-
Vitório JG, Duarte-Andrade FF, Pereira TDSF, Melo-Braga MN, Canuto GAB, Macedo AN, Lebron YAR, Moreira VR, Felicori LF, Lange LC, Santos LVS, Larsen MR, Gomes CC, and Gomez RS
- Subjects
- Humans, Jaw metabolism, Jaw pathology, Metabolomics, Mutation, Proteomics, Proto-Oncogene Proteins p21(ras) genetics, Proto-Oncogene Proteins p21(ras) metabolism, Granuloma, Giant Cell genetics, Granuloma, Giant Cell metabolism, TRPV Cation Channels genetics, TRPV Cation Channels metabolism
- Abstract
Background: Giant cell granuloma of the jaws are benign osteolytic lesions of the jaws. These lesions are genetically characterized by mutually exclusive somatic mutations at TRPV4, KRAS, and FGFR1, and a fourth molecular subgroup which is wild-type for the three mutations. Irrespective of the molecular background, giant cell granulomas show MAPK/ERK activation. However, it remains unclear if these mutations lead to differences in their molecular signaling in giant cell granulomas., Methods: Metabolomics, proteomics, and phosphoproteomics analyses were carried out in formalin-fixed paraffin-embedded samples of giant cell granuloma of the jaws. The study cohort consisted of five lesions harboring mutations in FGFR1, six in KRAS, five in TRPV4, and five that were wild-type for these mutations., Results: Lesions harboring KRAS or FGFR1 mutations showed overall similar proteomics and metabolomics profiles. In all four groups, metabolic pathways showed similarity in apoptosis, cell signaling, gene expression, cell differentiation, and erythrocyte activity. Lesions harboring TRPV4 mutations showed a greater number of enriched pathways related to tissue architecture. On the other hand, the wild-type group presented increased number of enriched pathways related to protein metabolism compared to the other groups., Conclusion: Despite some minor differences, our results revealed an overall similar molecular profile among the groups with different mutational profile at the metabolic, proteic, and phosphopeptidic levels., (© 2022 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.)
- Published
- 2022
- Full Text
- View/download PDF
50. Necrotic lesion in the palate.
- Author
-
Pontes FSC, de Souza RHA, Moura FA, Pereira GG, Macedo DV, Ferreira GBM, Santos VL, Gomes CC, and Pontes HAR
- Subjects
- Humans, Necrosis, Palate pathology
- Published
- 2022
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.